Global Biosimilars Market Professional Survey Report 2018

January 2018 | 104 pages | ID: GB31D8CCE10EN
QYResearch

Abstracts

This report studies Biosimilars in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Sandoz International GmbH
• Teva Pharmaceuticals Industries
• Amgen Inc
• Biocon
• Dr. Reddy’s Laboratories
• F. Hoffmann-La Roche
• Celltrion
• Samsung Bioepis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
• Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
• Peptides (Glucagon, Calcitonin)

By Application, the market can be split into

• Oncology
• Blood Disorders

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Biosimilars Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF BIOSIMILARS

1.1 Definition and Specifications of Biosimilars
  1.1.1 Definition of Biosimilars
  1.1.2 Specifications of Biosimilars
1.2 Classification of Biosimilars
  1.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
  1.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
  1.2.3 Peptides (Glucagon, Calcitonin)
1.3 Applications of Biosimilars
  1.3.1 Oncology
  1.3.2 Blood Disorders
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOSIMILARS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biosimilars
2.3 Manufacturing Process Analysis of Biosimilars
2.4 Industry Chain Structure of Biosimilars

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOSIMILARS

3.1 Capacity and Commercial Production Date of Global Biosimilars Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Biosimilars Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Biosimilars Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Biosimilars Major Manufacturers in 2016

4 GLOBAL BIOSIMILARS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Biosimilars Capacity and Growth Rate Analysis
  4.2.2 2016 Biosimilars Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Biosimilars Sales and Growth Rate Analysis
  4.3.2 2016 Biosimilars Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Biosimilars Sales Price
  4.4.2 2016 Biosimilars Sales Price Analysis (Company Segment)

5 BIOSIMILARS REGIONAL MARKET ANALYSIS

5.1 North America Biosimilars Market Analysis
  5.1.1 North America Biosimilars Market Overview
  5.1.2 North America 2012-2017E Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Biosimilars Sales Price Analysis
  5.1.4 North America 2016 Biosimilars Market Share Analysis
5.2 China Biosimilars Market Analysis
  5.2.1 China Biosimilars Market Overview
  5.2.2 China 2012-2017E Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Biosimilars Sales Price Analysis
  5.2.4 China 2016 Biosimilars Market Share Analysis
5.3 Europe Biosimilars Market Analysis
  5.3.1 Europe Biosimilars Market Overview
  5.3.2 Europe 2012-2017E Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Biosimilars Sales Price Analysis
  5.3.4 Europe 2016 Biosimilars Market Share Analysis
5.4 Southeast Asia Biosimilars Market Analysis
  5.4.1 Southeast Asia Biosimilars Market Overview
  5.4.2 Southeast Asia 2012-2017E Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Biosimilars Sales Price Analysis
  5.4.4 Southeast Asia 2016 Biosimilars Market Share Analysis
5.5 Japan Biosimilars Market Analysis
  5.5.1 Japan Biosimilars Market Overview
  5.5.2 Japan 2012-2017E Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Biosimilars Sales Price Analysis
  5.5.4 Japan 2016 Biosimilars Market Share Analysis
5.6 India Biosimilars Market Analysis
  5.6.1 India Biosimilars Market Overview
  5.6.2 India 2012-2017E Biosimilars Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Biosimilars Sales Price Analysis
  5.6.4 India 2016 Biosimilars Market Share Analysis

6 GLOBAL 2012-2017E BIOSIMILARS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Biosimilars Sales by Type
6.2 Different Types of Biosimilars Product Interview Price Analysis
6.3 Different Types of Biosimilars Product Driving Factors Analysis
  6.3.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) of Biosimilars Growth Driving Factor Analysis
  6.3.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) of Biosimilars Growth Driving Factor Analysis
  6.3.3 Peptides (Glucagon, Calcitonin) of Biosimilars Growth Driving Factor Analysis

7 GLOBAL 2012-2017E BIOSIMILARS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Biosimilars Consumption by Application
7.2 Different Application of Biosimilars Product Interview Price Analysis
7.3 Different Application of Biosimilars Product Driving Factors Analysis
  7.3.1 Oncology of Biosimilars Growth Driving Factor Analysis
  7.3.2 Blood Disorders of Biosimilars Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF BIOSIMILARS

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Biosimilars Business Region Distribution Analysis
8.2 Sandoz International GmbH
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Sandoz International GmbH 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Sandoz International GmbH 2016 Biosimilars Business Region Distribution Analysis
8.3 Teva Pharmaceuticals Industries
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Teva Pharmaceuticals Industries 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Teva Pharmaceuticals Industries 2016 Biosimilars Business Region Distribution Analysis
8.4 Amgen Inc
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Amgen Inc 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Amgen Inc 2016 Biosimilars Business Region Distribution Analysis
8.5 Biocon
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Biocon 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Biocon 2016 Biosimilars Business Region Distribution Analysis
8.6 Dr. Reddy’s Laboratories
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Dr. Reddy’s Laboratories 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Dr. Reddy’s Laboratories 2016 Biosimilars Business Region Distribution Analysis
8.7 F. Hoffmann-La Roche
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 F. Hoffmann-La Roche 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 F. Hoffmann-La Roche 2016 Biosimilars Business Region Distribution Analysis
8.8 Celltrion
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Celltrion 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Celltrion 2016 Biosimilars Business Region Distribution Analysis
8.9 Samsung Bioepis
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Samsung Bioepis 2016 Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Samsung Bioepis 2016 Biosimilars Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF BIOSIMILARS MARKET

9.1 Global Biosimilars Market Trend Analysis
  9.1.1 Global 2017-2022 Biosimilars Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Biosimilars Sales Price Forecast
9.2 Biosimilars Regional Market Trend
  9.2.1 North America 2017-2022 Biosimilars Consumption Forecast
  9.2.2 China 2017-2022 Biosimilars Consumption Forecast
  9.2.3 Europe 2017-2022 Biosimilars Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Biosimilars Consumption Forecast
  9.2.5 Japan 2017-2022 Biosimilars Consumption Forecast
  9.2.6 India 2017-2022 Biosimilars Consumption Forecast
9.3 Biosimilars Market Trend (Product Type)
9.4 Biosimilars Market Trend (Application)

10 BIOSIMILARS MARKETING TYPE ANALYSIS

10.1 Biosimilars Regional Marketing Type Analysis
10.2 Biosimilars International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biosimilars by Region
10.4 Biosimilars Supply Chain Analysis

11 CONSUMERS ANALYSIS OF BIOSIMILARS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL BIOSIMILARS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilars
Table Product Specifications of Biosimilars
Table Classification of Biosimilars
Figure Global Production Market Share of Biosimilars by Type in 2016
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Picture
Table Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Picture
Table Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Figure Peptides (Glucagon, Calcitonin) Picture
Table Major Manufacturers of Peptides (Glucagon, Calcitonin)
Table Applications of Biosimilars
Figure Global Consumption Volume Market Share of Biosimilars by Application in 2016
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Blood Disorders Examples
Table Major Consumers in Blood Disorders
Figure Market Share of Biosimilars by Regions
Figure North America Biosimilars Market Size (Million USD) (2012-2022)
Figure China Biosimilars Market Size (Million USD) (2012-2022)
Figure Europe Biosimilars Market Size (Million USD) (2012-2022)
Figure Southeast Asia Biosimilars Market Size (Million USD) (2012-2022)
Figure Japan Biosimilars Market Size (Million USD) (2012-2022)
Figure India Biosimilars Market Size (Million USD) (2012-2022)
Table Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biosimilars in 2016
Figure Manufacturing Process Analysis of Biosimilars
Figure Industry Chain Structure of Biosimilars
Table Capacity and Commercial Production Date of Global Biosimilars Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Biosimilars Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Biosimilars Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Biosimilars Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Biosimilars 2012-2017
Figure Global 2012-2017E Biosimilars Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Biosimilars Market Size (Value) and Growth Rate
Table 2012-2017E Global Biosimilars Capacity and Growth Rate
Table 2016 Global Biosimilars Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Biosimilars Sales (K MT) and Growth Rate
Table 2016 Global Biosimilars Sales (K MT) List (Company Segment)
Table 2012-2017E Global Biosimilars Sales Price (USD/MT)
Table 2016 Global Biosimilars Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Biosimilars 2012-2017E
Figure North America 2012-2017E Biosimilars Sales Price (USD/MT)
Figure North America 2016 Biosimilars Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Biosimilars 2012-2017E
Figure China 2012-2017E Biosimilars Sales Price (USD/MT)
Figure China 2016 Biosimilars Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Biosimilars 2012-2017E
Figure Europe 2012-2017E Biosimilars Sales Price (USD/MT)
Figure Europe 2016 Biosimilars Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Biosimilars 2012-2017E
Figure Southeast Asia 2012-2017E Biosimilars Sales Price (USD/MT)
Figure Southeast Asia 2016 Biosimilars Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Biosimilars 2012-2017E
Figure Japan 2012-2017E Biosimilars Sales Price (USD/MT)
Figure Japan 2016 Biosimilars Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Biosimilars 2012-2017E
Figure India 2012-2017E Biosimilars Sales Price (USD/MT)
Figure India 2016 Biosimilars Sales Market Share
Table Global 2012-2017E Biosimilars Sales (K MT) by Type
Table Different Types Biosimilars Product Interview Price
Table Global 2012-2017E Biosimilars Sales (K MT) by Application
Table Different Application Biosimilars Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Biosimilars Business Region Distribution
Table Sandoz International GmbH Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sandoz International GmbH Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sandoz International GmbH Biosimilars Business Region Distribution
Table Teva Pharmaceuticals Industries Information List
Table Product A Overview
Table Product B Overview
Table 2015 Teva Pharmaceuticals Industries Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Teva Pharmaceuticals Industries Biosimilars Business Region Distribution
Table Amgen Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Inc Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Amgen Inc Biosimilars Business Region Distribution
Table Biocon Information List
Table Product A Overview
Table Product B Overview
Table 2016 Biocon Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Biocon Biosimilars Business Region Distribution
Table Dr. Reddy’s Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dr. Reddy’s Laboratories Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Dr. Reddy’s Laboratories Biosimilars Business Region Distribution
Table F. Hoffmann-La Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 F. Hoffmann-La Roche Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 F. Hoffmann-La Roche Biosimilars Business Region Distribution
Table Celltrion Information List
Table Product A Overview
Table Product B Overview
Table 2016 Celltrion Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Celltrion Biosimilars Business Region Distribution
Table Samsung Bioepis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Samsung Bioepis Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Samsung Bioepis Biosimilars Business Region Distribution
Figure Global 2017-2022 Biosimilars Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Biosimilars Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Biosimilars Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Biosimilars by Type 2017-2022
Table Global Consumption Volume (K MT) of Biosimilars by Application 2017-2022
Table Traders or Distributors with Contact Information of Biosimilars by Region